Since high ClpP levels have previously been correlated with poor metastasis-free survival in NSCLC, these SNPs may contribute to a more aggressive disease phenotype by enabling cancer cells to better withstand metabolic and oxidative stress through enhanced mitochondrial proteolysis. The gene discussed is CLPP; the disease is cancer.